1、 Exhibit 99.1CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2024 RESULTSFourth Quarter HighlightsTotal revenues increased to$97.7 billion,up 4.2%compared to prior yearGAAP diluted EPS of$1.30 and Adjusted EPS of$1.19Full-Year HighlightsTotal revenues increased to$372.8 billion,up 4.2%co

2、mpared to prior yearGAAP diluted EPS of$3.66 and Adjusted EPS of$5.42Generated cash flow from operations of$9.1 billion2025 Full-Year GuidanceGAAP diluted EPS guidance range of$4.58 to$4.83Adjusted EPS guidance range of$5.75 to$6.00Cash flow from operations guidance of approximately$6.5 billionCEO C

3、ommentary“Our integrated model allows us to uniquely deliver a simpler,connected experience that saves time,saves money,and improves health.We have continued to see growth in key areas of our business,including the Pharmacy and Consumer Wellness segment,while we address the industry-wide challenges

4、that have impacted our Health Care Benefits segment.Through the continued dedication of our colleagues,we will be positioned for strong performance in 2025 as we deliver simply better care for consumers while improving outcomes and reducing costs.”David Joyner,CVS Health President and CEOWOONSOCKET,

5、RHODE ISLAND,February 12,2025-CVS Health Corporation(NYSE:CVS)today announced operating results for the three months and year ended December 31,2024.Financial Results SummaryThree Months Ended December 31,In millions,except per share amounts20242023ChangeTotal revenues$97,710$93,813$3,897 Operating

6、income 2,368 3,373 (1,005)Adjusted operating income(1)2,728 4,227 (1,499)Diluted earnings per share$1.30$1.58$(0.28)Adjusted EPS(2)$1.19$2.12$(0.93)Fourth quarter GAAP diluted EPS of$1.30 decreased from$1.58 in the prior year and Adjusted EPS of$1.19 decreased from$2.12 in the prior year,primarily d